1. Inhibitory Antibodies

Inhibitory Antibodies

Inhibitory Antibodies (4):

Cat. No. Product Name Purity Concentration
  • HY-P9907
    Trastuzumab 99.30%
    Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2.
  • HY-P9906
    Bevacizumab >99.0%
    Bevacizumab, a humanized monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity. MW : 149 kDa.
  • HY-P9905
    Cetuximab 99.70%
    Cetuximab is a monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with antitumor activity.
  • HY-108730
    Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity property.